Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Kachroo

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
British Journal of Cancer|November 22, 2012
Evidence for downregulation of the negative regulator SPRED2 in clinical prostate cancerN Kachroo, T Valencia, A Y Warren, et al.
Journal of Cancer Research and Clinical Oncology|April 15, 2010
Outcomes and predictive factors for biochemical relapse following primary androgen deprivation therapy in men with bone scan negative prostate cancerS Hori, T Jabbar, N Kachroo, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
British Journal of Cancer|November 22, 2012
Evidence for downregulation of the negative regulator SPRED2 in clinical prostate cancerN Kachroo, T Valencia, A Y Warren, et al.
Journal of Cancer Research and Clinical Oncology|April 15, 2010
Outcomes and predictive factors for biochemical relapse following primary androgen deprivation therapy in men with bone scan negative prostate cancerS Hori, T Jabbar, N Kachroo, et al.
Pageof 1